APA (7th ed.) Citation

M, C., I, B., E, F., J, G. G., L, R., MT, D. P., . . . JP, G. (2022). Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study. Inflammatory bowel diseases, 28(11), 1725. https://doi.org/10.1093/ibd/izab357

Chicago Style (17th ed.) Citation

M, Chaparro, et al. "Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study." Inflammatory Bowel Diseases 28, no. 11 (2022): 1725. https://doi.org/10.1093/ibd/izab357.

MLA (9th ed.) Citation

M, Chaparro, et al. "Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study." Inflammatory Bowel Diseases, vol. 28, no. 11, 2022, p. 1725, https://doi.org/10.1093/ibd/izab357.